Vale Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Vale Indonesia Tbk. trades at Rp5,225 (market cap 52.7T, 13.56M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume). The key difference: Vale Indonesia Tbk. is far larger — about 320.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Vale Indonesia Tbk. is more actively traded (13.56M versus 62.5K). Which is the better fit depends on your goals.
| INCO | OBAT | |
|---|---|---|
Market Cap | 52.7T | 164.65B |
Volume | 13.56M | 62.5K |
Lot | 135.56K | 625 |
Turnover | 70.45B | 15.03M |
Average Price | 5,196.85 | 240.55 |
Value | 70.45B | 15.03M |
Indicative Equilibrium Price | 5,225 | 238 |
Indicative Equilibrium Volume | 3.17K | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Vale Indonesia Tbk, formely PT International Nickel Indonesia, was established on July 25, 1968. PT. INCO produces nickel in matte, an intermediate product, from lateritic ores at its integrated mining and processing facilities near Soroako on the island of Sulawesi. The company is owned 58.7 % by Inco Limited of Canada, 20.1 % by Sumitomo Metal Mining Co., Ltd. of Japan.The Company is PMA
Read more on INCO →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →